CSTL - Castle Biosciences Inc. Common Stock

Castle Biosciences Inc. (CSTL)

NGM · Common · CUSIP 14843C105

Last Price•••.••

Current Yield•.••%

Yield to Call•.••%

Yield to Worst•.••%

Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CSTL and every other security on QuantumOnline.

Overview Financials 🔒 Earnings 🔒 Dividends 🔒 Analysts 🔒 Ownership 🔒 ESG 🔒 Technicals 🔒

🔒

Price chart and 15 days of daily prices

Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type: Common Stock
CUSIP: 14843C105
Market Cap: Mid Cap
IPO: 7/25/2019 · $16.00/share

Links: Home Page Investor Relations News

Business: Castle Biosciences Inc. is a skin cancer diagnostics company focused on providing physicians and patients with personalized, clinically actionable genomic information enabling more accurate treatment plan decisions. From its formation in 2008, Castle Biosciences has applied emerging artificial intelligence techniques in molecular diagnostics to improve patient care and outcomes.

Company Contact

CEO: Derek J. Maetzold
CFO: Frank Stokes
Headquarters: 505 S. Friendswood Drive, Suite 401, Friendswood, TX 77546
Phone: 866-788-9007 · Toll-Free 866-788-9007
Investor Relations: Camilla Zuckero · 832-835-5158 · czuckero@castlebiosciences.com
General Email: IR@castlebiosciences.com
Email Form: Contact Form »
SEC EDGAR Filings: View filings »